Le Lézard
Classified in: Health
Subject: PDT

New Behavioral Health Magazine 'Resilient Health' Turns the Focus to the Link Between Addiction and Mental Health


SAN CLEMENTE, Calif., Feb. 22, 2018 /PRNewswire/ -- The inaugural issue of 'Resilient Health' is now available. Resilient Health is a new and dynamic digital magazine which will be a resourceful publication for professionals in the addiction and mental health field to read. As a complimentary monthly digital magazine, Resilient Health is designed to provide breaking news, clinical updates and detailed examinations of disorders and treatment methods. To sign up for a free subscription to Resilient Health, click here.

Behavioral Health Treatment Services (PRNewsFoto/Sovereign Health Group)

What to expect when reading Resilient Health:

The first issue focuses on the diagnosis and treatment of borderline personality disorder (BPD), a common yet often undiagnosed and untreated mental health condition. BPD is caused by a combination of factors and can be moderate to severe in nature. In contrast to people with antisocial personality disorder, who often cause harm to others, people with BPD tend to cause problems for themselves. They are at high risk for suicide, unemployment, homelessness and societal ostracization. Fortunately, BPD and co-occurring disorders such as addiction can be treated with specialized forms of psychotherapy; find out about treatment options in this month's Resilient Health.

The February issue also includes discussion of how the behavioral health field can respond to the mushrooming opioid epidemic, the dangers of the drug U-47700 (also called U-4, Pink or Pinky) and an inspiring first-person story on one man's road to recovery from BPD and alcoholism.

Every issue of Resilient Health will provide professionals with informative articles, interviews and fresh perspectives on mental health and substance abuse issues, in addition to first-person patient stories, quizzes, fast facts, news updates and a section for reader comments and other general feedback.

The magazine is published by Sovereign Health, a leading national provider of behavioral health treatment services. For information about Resilient Health, visit www.reshealth.net, and to reach the editor, contact [email protected].

About Sovereign Health
Sovereign Health's facilities are licensed in accordance with state regulations. The Joint Commission is the nation's leading health care standards-setting and accrediting organization, and sets a very high bar for qualifying for the Gold Seal designation. Sovereign's extensive national network of nine facilities across five states also enjoys the distinction of being accredited to provide concurrent mental health and substance use treatment, a rarity in the field.

Sovereign Health's mission is to provide a broad spectrum of high-quality behavioral health treatment services for adults and adolescents, including support services for family members. One factor that differentiates Sovereign from other treatment providers has been the company's ability to offer separate mental health and addiction or dual diagnosis treatment programs at its facilities. For more information, visit www.sovhealth.com.

 

SOURCE Sovereign Health


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: